Wang Y - Search Results

1

Optimal Therapies for Recurrent Glioblastoma: A Bayesian Network Meta-Analysis.

Chen W, Wang Y, Zhao B, Liu P, Liu L, Wang Y, Ma W. Chen W, et al. Among authors: wang y. Front Oncol. 2021 Mar 29;11:641878. doi: 10.3389/fonc.2021.641878. eCollection 2021. Front Oncol. 2021. PMID: 33854975 Free PMC article.

2

Quantitative and Visual Characteristics of Primary Central Nervous System Lymphoma on ¹⁸F-FDG-PET.

Liu D, Kong Z, Wang Y, Chen W, Wang Y, Chen W, Liu L, Dang Y, Ma W, Wang Y, Cheng X. Liu D, et al. Among authors: wang y. Interdiscip Sci. 2019 Jun;11(2):300-306. doi: 10.1007/s12539-019-00333-y. Epub 2019 Jul 1. Interdiscip Sci. 2019. PMID: 31264053

3

¹⁸F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma.

Kong Z, Lin Y, Jiang C, Li L, Liu Z, Wang Y, Dai C, Liu D, Qin X, Wang Y, Liu Z, Cheng X, Tian J, Ma W. Kong Z, et al. Among authors: wang y. Cancer Imaging. 2019 Aug 19;19(1):58. doi: 10.1186/s40644-019-0246-0. Cancer Imaging. 2019. PMID: 31426864 Free PMC article.

4

Progress and Prospects of Recurrent Glioma: A Recent Scientometric Analysis of the Web of Science in 2019.

Chen W, Lei C, Liu P, Liu Y, Guo X, Kong Z, Wang Y, Dai C, Wang Y, Ma W, Wang Y. Chen W, et al. Among authors: wang y. World Neurosurg. 2020 Feb;134:e387-e399. doi: 10.1016/j.wneu.2019.10.078. Epub 2019 Oct 19. World Neurosurg. 2020. PMID: 31639500 Review.

5

Fusion Radiomics Features from Conventional MRI Predict MGMT Promoter Methylation Status in Lower Grade Gliomas.

Jiang C, Kong Z, Liu S, Feng S, Zhang Y, Zhu R, Chen W, Wang Y, Lyu Y, You H, Zhao D, Wang R, Wang Y, Ma W, Feng F. Jiang C, et al. Among authors: wang y, wang r. Eur J Radiol. 2019 Dec;121:108714. doi: 10.1016/j.ejrad.2019.108714. Epub 2019 Oct 19. Eur J Radiol. 2019. PMID: 31704598

6

Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.

Zhao B, Wang Y, Wang Y, Chen W, Liu PH, Kong Z, Dai C, Wang Y, Ma W. Zhao B, et al. Among authors: wang y. J Cell Physiol. 2021 Jan;236(1):507-522. doi: 10.1002/jcp.29878. Epub 2020 Jun 22. J Cell Physiol. 2021. PMID: 32572951

7

Efficacy and safety of therapies for EGFR-mutant non-small cell lung cancer with brain metastasis: an evidence-based Bayesian network pooled study of multivariable survival analyses.

Zhao B, Wang Y, Wang Y, Chen W, Zhou L, Liu PH, Kong Z, Dai C, Wang Y, Ma W. Zhao B, et al. Among authors: wang y. Aging (Albany NY). 2020 Jul 15;12(14):14244-14270. doi: 10.18632/aging.103455. Epub 2020 Jul 15. Aging (Albany NY). 2020. PMID: 32669477 Free PMC article.

8

Effects of oncolytic viruses and viral vectors on immunity in glioblastoma.

Liu P, Wang Y, Wang Y, Kong Z, Chen W, Li J, Chen W, Tong Y, Ma W, Wang Y. Liu P, et al. Among authors: wang y. Gene Ther. 2022 Apr;29(3-4):115-126. doi: 10.1038/s41434-020-00207-9. Epub 2020 Nov 15. Gene Ther. 2022. PMID: 33191399 Review.

9

Radiotherapy in combination with systemic therapies for brain metastases: current status and progress.

Liu L, Chen W, Zhang R, Wang Y, Liu P, Lian X, Zhang F, Wang Y, Ma W. Liu L, et al. Among authors: wang y. Cancer Biol Med. 2020 Nov 15;17(4):910-922. doi: 10.20892/j.issn.2095-3941.2020.0109. Epub 2020 Dec 15. Cancer Biol Med. 2020. PMID: 33299643 Free PMC article. Review.

10

NTRK Fusions and TRK Inhibitors: Potential Targeted Therapies for Adult Glioblastoma.

Wang Y, Long P, Wang Y, Ma W. Wang Y, et al. Front Oncol. 2020 Nov 30;10:593578. doi: 10.3389/fonc.2020.593578. eCollection 2020. Front Oncol. 2020. PMID: 33330081 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

296,232 results

Search Page

Filters